Saturday, Sep 19, 2026

"anti-diabetes-drug"

AstraZeneca gets marketing authorisation to use anti-diabetes drug for kidney disease

The study results of dapagliflozin showed significant benefits in reducing CKD progression in patients with and without type-2 diabetes.

Latest News

Hyderabad: Family returning from Ganesh immersion dies in road accident on NH 44

31 minutes ago
Danam Nagendar’s disqualification sets stage for Khairatabad by-election

6 hours ago
Bus-tractor crash leaves 30 injured in Siddipet

7 hours ago
Congress leader dies by suicide in Hanamkonda

7 hours ago
Janwada farmhouse belongs to me, not KTR, says owner Pradeep Reddy

7 hours ago
KTR challenges Revanth Reddy to prove Rs 1-lakh-crore land claim

7 hours ago
Cyberabad civic body demolishes 14 unauthorised constructions

7 hours ago
Editorial: Mecca pact comes a cropper

8 hours ago